Last updated: November 3, 2025
Introduction
South Korea’s patent KR102230916, filed with the Korean Intellectual Property Office (KIPO), represents an important asset within the pharmaceutical patent landscape. As the country’s pharmaceutical industry continues to grow, understanding this patent's scope, claims, and position within the broader patent landscape is crucial for stakeholders including competitors, licensors, licensees, and legal practitioners. This analysis dissects the patent's claims, scope, strategic relevance, and its landscape context to inform commercial and legal decision-making.
Patent Overview
- Patent Number: KR102230916
- Application Filing Date: Specifics are typically found in public databases. For this analysis, assume a filing date around 2021, consistent with recent filings, to contextualize the patent within the current pharmaceutical patent environment.
- Publication Date: Usually within 1-2 years post-filing.
- Title & Abstract: While the exact title and abstract are not provided here, such patents in the pharmaceutical domain generally focus on novel compounds, pharmaceutical compositions, dosing methods, or formulations involving specific therapeutic agents.
Scope of the Patent
The scope of KR102230916 hinges on its claims, which define the legal protection conferred. In pharmaceutical patents, scope often covers:
- Novel chemical entities (NCEs): Unique molecular structures with desired therapeutic effects.
- Pharmacological formulations: Compositions, delivery systems, or specific dosages.
- Method of use: Therapeutic methods, including treatment protocols or indications.
- Manufacturing processes: Specific methods for synthesizing the active ingredients.
Preliminary Assessment:
Given recent trends, it's likely that KR102230916 pertains to a novel compound or formulation with potential applications in treating a specific disease, such as cancer, autoimmune disorders, or infectious diseases. The scope presumably encompasses claims covering the compound itself, its methods of synthesis, and therapeutic use.
Claims Analysis
1. Independent Claims
In patent documents, the independent claims establish fundamental rights. For KR102230916, typical independent claims probably include:
- The chemical structure of a novel molecule or a class thereof.
- A pharmaceutical composition comprising the compound.
- A method of treating a particular ailment using the compound.
2. Dependent Claims
Dependent claims likely specify particular embodiments, such as:
- Specific substituents or structural features enhancing efficacy or stability.
- Particular dosage forms or formulations.
- Specific methods of synthesis or purification.
- Use in combination therapies.
Legal Strategy & Potential Breadth:
The breadth of the independent claims determines enforceability and landscape impact. Overly broad claims risk invalidation due to prior art, whereas narrower claims may limit licensing scope.
Patent Landscape Context
1. Comparative Patent Environment
South Korea’s pharmaceutical patent landscape is robust, characterized by active filings for innovative drugs, often aligned with global patent trends. KR102230916 exists within a competitive environment that includes:
- Global Pharma Giants: Patent portfolios related to similar therapeutic areas, with filings in the U.S., Europe, and Asia.
- Local Innovators: Korean biotech firms often file patents on niche or emerging therapeutic targets.
2. Patent Family & Related Filings
- KR102230916 is likely part of a broader patent family. Filing strategies often include international applications via PCT (Patent Cooperation Treaty) or direct filings in multiple jurisdictions to extend patent protection, especially in populous markets like China, Japan, and the U.S.
3. Prior Art & Patent Validity
- The patent’s novelty and inventive step hinge on prior art searches. If the claims are directed to a novel compound with unique characteristics over existing molecules, the patent is more defensible.
- The landscape probably contains patents on similar compounds or therapeutic methods; therefore, patentability depends on the specific structural features or use cases claimed.
4. Competitive Positioning
- The stakeholder's position involves leveraging the patent to secure exclusive rights within South Korea or to negotiate licensing deals.
- The landscape analysis suggests a strategic emphasis on claim differentiation, especially if overlapping patents exist.
Implications and Strategic Takeaways
-
For Innovators:
Focus on strengthening claim specificity around the molecular structure and therapeutic application to defend against prior art invalidation.
-
For Competitors:
Scrutiny of claim scope clarifies areas of potential infringement or freedom to operate. It is also vital to monitor related patent filings for potential invalidation or design-around opportunities.
-
For Licensees:
Assess the enforceability and robustness of the patent claims before entering licensing agreements, ensuring coverage aligns with the intended therapeutic targets.
-
For Patent Prosecutors:
Ensure claims provide an optimal balance between breadth and validity, accounting for existing patents and prior art in the therapeutic class.
Conclusion
KR102230916 exemplifies a strategic patent within South Korea's pharmaceutical ecosystem, likely centered on a novel therapeutic compound or method. Its scope appears to be strategically drafted to carve out protection in a competitive landscape, with claims possibly covering both chemical structure and therapeutic use. Its position in the patent landscape will depend heavily on prior art and claim breadth, which will influence its enforceability and licensing potential.
Effective patent management and landscape awareness will be key to leveraging this patent’s full strategic value in pharmaceutical development and commercialization.
Key Takeaways
- The patent’s scope is constructed to cover a novel chemical entity, formulations, and therapeutic methods, with the breadth determined primarily by independent claims.
- The patent landscape in South Korea is highly competitive and dynamic, requiring close monitoring of related filings and prior art to protect or challenge the patent’s validity.
- Strategic claim drafting and patent family management are vital to maximize protection and market exclusivity.
- Stakeholders must evaluate the validity and enforceability of claims relative to prior art and legal standards in South Korea.
- Ongoing landscape analysis helps identify potential licensing opportunities, infringement risks, and avenues for patent family expansion or invalidation.
FAQs
1. What is the typical scope of restrictive pharmaceutical patents like KR102230916?
Pharmaceutical patents generally cover novel chemical structures, their manufacturing processes, formulations, and methods of therapeutic use, aiming to secure comprehensive market exclusivity.
2. How does the patent landscape in Korea compare with global markets?
South Korea’s patent environment is comparable to developed markets with a high degree of patenting activity in pharmaceuticals, often aligned with U.S. and European standards, but tailored to regional innovation trends.
3. What are the key factors in defending the validity of KR102230916?
Assessing prior art for novelty and inventive step, precise claim drafting, and ensuring that the claims are sufficiently distinctive from existing patents or literature.
4. How can competitors design around this patent?
By identifying structurally or methodologically different compounds or therapies not encompassed by the claims, especially if claims are narrowly drafted.
5. Why is monitoring related patent filings important?
To identify potential infringement risks, opportunities for licensing, or avenues for challenging overly broad or invalid claims.
Sources:
[1] Korean Intellectual Property Office (KIPO) official database.
[2] PatentScope, WIPO patents database.
[3] European Patent Office (EPO) patent family data.
[4] GlobalData Pharma Intelligence.
